These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9294701

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.
    van Ingen J, Hoefsloot W, Mouton JW, Boeree MJ, van Soolingen D.
    Int J Antimicrob Agents; 2013 Jul; 42(1):80-2. PubMed ID: 23664674
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
    Jadaun GP, Agarwal C, Sharma H, Ahmed Z, Upadhyay P, Faujdar J, Gupta AK, Das R, Gupta P, Chauhan DS, Sharma VD, Katoch VM.
    J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
    [Abstract] [Full Text] [Related]

  • 5. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.
    Hoffner SE, Svenson SB, Källenius G.
    Eur J Clin Microbiol; 1987 Oct; 6(5):530-5. PubMed ID: 3436314
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility of mycobacteria to fusidic acid.
    Hoffner SE, Olsson-Liljequist B, Rydgård KJ, Svenson SB, Källenius G.
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):294-7. PubMed ID: 2112466
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol.
    Abate G, Miörner H.
    J Antimicrob Chemother; 1998 Dec; 42(6):735-40. PubMed ID: 10052896
    [Abstract] [Full Text] [Related]

  • 8. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M, Goda T.
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [Abstract] [Full Text] [Related]

  • 9. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
    Banks J, Jenkins PA.
    Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
    Guo N, Wu J, Fan J, Yuan P, Shi Q, Jin K, Cheng W, Zhao X, Zhang Y, Li W, Tang X, Yu L.
    Lett Appl Microbiol; 2014 Apr; 58(4):344-9. PubMed ID: 24330002
    [Abstract] [Full Text] [Related]

  • 13. Activity of subinhibitory concentrations of dapsone alone and in combination with cell-wall inhibitors against Mycobacterium avium complex organisms.
    Rastogi N, Goh KS, Labrousse V.
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):954-8. PubMed ID: 8187794
    [Abstract] [Full Text] [Related]

  • 14. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
    Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Källenius G.
    J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
    [Abstract] [Full Text] [Related]

  • 15. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM, Ahmad S, Mokaddas E.
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [Abstract] [Full Text] [Related]

  • 16. Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis.
    Aguilar-Pérez C, Gracia B, Rodrigues L, Vitoria A, Cebrián R, Deboosère N, Song OR, Brodin P, Maqueda M, Aínsa JA.
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987141
    [Abstract] [Full Text] [Related]

  • 17. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A, Onnis V, Saddi B, Congiu C, Schivo ML, Cocco MT.
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [Abstract] [Full Text] [Related]

  • 18. [Distribution and drug resistance of nontuberculous Mycobacteria in Beijing].
    Zhang J, Su JR, Ding BC, Liu JW, Yi JL, Yang XY, Wang NH, Wang SM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar 12; 40(3):210-214. PubMed ID: 28297817
    [Abstract] [Full Text] [Related]

  • 19. [Prospects for development of new antituberculous drugs].
    Tomioka H.
    Kekkaku; 2002 Aug 12; 77(8):573-84. PubMed ID: 12235850
    [Abstract] [Full Text] [Related]

  • 20. Reliability of mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin.
    Bergmann JS, Woods GL.
    J Clin Microbiol; 1997 Dec 12; 35(12):3325-7. PubMed ID: 9399548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.